The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that ...
They need to be prescribed by a healthcare professional alongside programmes that help people lose weight and live healthier ...
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical ...
Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a ...
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...
Health Editor Amy Packer asks the medical experts to answer your most common questions about Ozempic, Mounjaro and Wegovy ...
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...
People taking the weight loss drug Zepbound experienced dramatically greater weight loss than competitor Wegovy in the first head-to-head trial.
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy ...
The guidelines are part of a national trend by municipal governments and private firms struggling to manage ballooning costs ...